NCT07398521CompletedNot Applicable
A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood
Cymbiotika, LLC1 site in 1 country60 target enrollmentStarted: October 14, 2025Last updated:
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change in Energy Levels
Study Overview
Brief Summary
This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Be male or female
- •Be aged 18-60
- •Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood
- •Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- •Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial.
- •Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period.
- •Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
- •Resides in the United States.
Exclusion Criteria
- •Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders.
- •Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients.
- •Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- •Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
- •History of diagnosed psychiatric or mood disorders.
- •History of diagnosed sleep disorders.
- •History of serious illness in the last three months.
- •History of substance abuse.
- •History of kidney disease.
- •History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes.
- •Planned surgery during the study period.
- •Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration.
- •Anyone unwilling to follow the study protocol.
Arms & Interventions
Liposomal Magnesium Complex
Experimental
Participants will consume one packet daily by squeezing the contents directly into the mouth.
Intervention: Liposomal Magnesium Complex (Dietary Supplement)
Outcomes
Primary Outcomes
Change in Energy Levels
Time Frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
Change in Mood
Time Frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
Secondary Outcomes
- Change in Stress Levels(Baseline, Day 3, Day 7, Day 10, Day 14)
- Change in Relaxation and Calmness(Baseline, Day 3, Day 7, Day 10, Day 14)
- Change in Balanced Mood(Baseline, Day 3, Day 7, Day 10, Day 14)
- Change in Sleep Quality(Baseline, Day 3, Day 7, Day 10, Day 14)
- Change in Muscle Tension(Baseline, Day 3, Day 7, Day 10, Day 14)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)NCT07309640Universiti Sains Malaysia38
Recruiting
Not Applicable
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant MedicationsNCT07380412Outliers, Inc.90
Completed
Phase 3
Study to Evaluate Safety, Tolerability and Efficacy in patients with Primary Biliary Cholangitis of Saroglitazar Magnesium-III
(EPICS-III).2024-518718-14-00Zydus Therapeutics Inc.6
Completed
Not Applicable
A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle SymptomsPremenstrual SyndromeNCT07267728Muse Nutrition Ltd40
Recruiting
Phase 4
Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparoscopic CholecystectomyPostoperative AnalgesiaNCT07328893Tata Main Hospital106